Captrust Financial Advisors Artivion, Inc. Transaction History

Captrust Financial Advisors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$15.73 - $22.91 $2,265 - $3,299	-144 Reduced 6.54%	2,057 $39,000
Q1 2022 May 16, 2022	BUY	$16.95 - $21.74 $22,441 - $28,783	1,324 Added 150.97%	2,201 $47,000
Q4 2021 Feb 14, 2022	SELL	$17.19 - $22.84 $618 - $822	-36 Reduced 3.94%	877 $18,000
Q3 2021 Nov 16, 2021	BUY	$22.29 - $28.7 $6,308 - $8,122	283 Added 44.92%	913 $20,000
Q2 2021 Aug 16, 2021	BUY	$22.32 - $32.07 $6,696 - $9,621	300 Added 90.91%	630 $18,000
Q1 2021 May 17, 2021	BUY	$22.07 - $26.31 $5,627 - $6,709	255 Added 340.0%	330 $7,000
Q4 2020 Feb 16, 2021	BUY	$16.76 - $23.74 $1,257 - $1,780	75 New	75 $2,000

179

36.1M

33K

900

Ticker AORT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,316,100
Market Cap $1.25B
Description
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.